INNATE PHARMA SA-SPONS ADR
IPHA · NASDAQ
Updated at 2026-10-15 08:53:25
- Today's High
- $1.46
- Today’s Low
- $1.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.44
- Previous Close
- $1.43
- Volume
- 9.39K
- Market Cap
- $140.07M
- P/E Ratio
- --
- EPS
- $-0.51
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 117, AVENUE DE LUMINY, MARSEILLE, FRANCE, 13009
- Country
- FR
- Listing Date
- 2006-10-31
- Fiscal Year End
- December
- Shares Outstanding
- 93.92M
- CIK
- 0001598599
- Website
- www.innate-pharma.com
Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France and internationally. The company is headquartered in Marseille, France.
Financial Metrics
Revenue
2026-06-30
$3.15M
2026-03-31
-$2.07M
2025-12-31
-$2.07M
2025-06-30
$4.86M
Operating Expenses
2026-06-30
$24.38M
2026-03-31
$46.44M
2025-12-31
$46.44M
2025-06-30
$9.76M
Net Income
2026-06-30
-$19.88M
2026-03-31
-$27.62M
2025-12-31
-$27.62M
2025-06-30
-$21.34M
Net Profit Margin
2026-06-30
-629.95%
2026-03-31
1.33K%
2025-12-31
1.33K%
2025-06-30
-439.17%
Earnings Per Share
2026-06-30
--
2026-03-31
$0.00
2025-12-31
--
2025-06-30
$-0.29
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.23M
2026-03-31
-$30.7M
2025-12-31
-$30.7M
2025-06-30
-$24.72M
Effective Tax Rate
2026-06-30
11.49%
2026-03-31
10.75%
2025-12-31
10.75%
2025-06-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $3.15M | -$2.07M | -$2.07M | $4.86M |
| Operating Expenses | $24.38M | $46.44M | $46.44M | $9.76M |
| Net Income | -$19.88M | -$27.62M | -$27.62M | -$21.34M |
| Net Profit Margin | -629.95% | 1.33K% | 1.33K% | -439.17% |
| Earnings Per Share | -- | $0.00 | -- | $-0.29 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.23M | -$30.7M | -$30.7M | -$24.72M |
| Effective Tax Rate | 11.49% | 10.75% | 10.75% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.